Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001179110-16-028450)

Filing Details

Accession Number:
0001179110-16-028450
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-08-09 15:12:46
Reporting Period:
2016-08-05
Filing Date:
2016-08-09
Accepted Time:
2016-08-09 15:12:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1578845 Allergan Plc AGN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1361580 Nesli Basgoz Clonshaugh Business And Technology Park,
Coolock, Co.
Dublin D17 E400		 Yes No No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares, Par Value $0.0001 Acquisiton 2016-08-05 1,889 $97.62 6,672 No 4 M Direct
Ordinary Shares, Par Value $0.0001 Disposition 2016-08-05 758 $253.02 5,914 No 4 S Direct
Ordinary Shares, Par Value $0.0001 Acquisiton 2016-08-08 201 $248.31 6,115 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 A Direct
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Employee Stock Option (right to buy) Acquisiton 2016-08-05 1,889 $0.00 1,889 $97.62
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
12,878 2016-08-07 No 4 M Direct
Footnotes
  1. This option award was scheduled to expire pursuant to its terms on August 7, 2016, and was exercised on the last trading day prior to expiration.
  2. These restricted stock units shall vest 100% on the earlier of (i) the day before the 2017 Annual Shareholder Meeting or (ii) May 4, 2017.
  3. Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.
  4. This option became vested and exercisable in four equal installments commencing on August 7, 2006.